Table 4.
Univariate and Multivariate Cox Regression Models Incorporating Prognostic Risk Models and NLR in Prediction of Cancer-Specific Survival, and Overall Survival
| Variable | Cancer-Specific Survival | Overall Survival | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate Model | Multivariate Model | Univariate Model | Multivariate Model | |||||
| HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
| UISS risk group | ||||||||
| Low | Reference | Reference | Reference | Reference | ||||
| Intermediate | 5.03 (1.43–17.68) | 0.012* | 4.82 (1.37–16.92) | 0.014* | 2.97 (1.24–7.12) | 0.015* | 2.92 (1.22–7.00) | 0.016 |
| High | 30.42 (8.65–106.93) | <0.001* | 29.03 (8.22–102.53) | <0.001* | 13.39 (5.33–33.63) | <0.001* | 13.01 (5.16–32.81) | <0.001* |
| NLR | <0.001* | <0.001* | ||||||
| <3.4 | Reference | Reference | Reference | Reference | ||||
| ≥3.4 | 7.14 (3.40–15.02) | 6.72 (3.16–14.28) | 5.28 (2.69–10.35) | <0.001* | 5.09 (2.58–10.03) | <0.001* | ||
| SSIGN risk group | ||||||||
| Low | Reference | Reference | Reference | Reference | ||||
| Intermediate | 9.78 (4.28–22.39) | <0.001* | 8.45 (3.67–19.44) | <0.001* | 5.78 (2.95–11.34) | <0.001* | 5.22 (2.65–10.28) | <0.001* |
| High | 36.27 (11.95–110.06) | <0.001* | 27.46 (8.96–84.15) | <0.001* | 15.94 (5.30–47.92) | <0.001* | 12.22 (4.03–37.10) | <0.001* |
| NLR | ||||||||
| <3.4 | Reference | Reference | Reference | Reference | ||||
| ≥3.4 | 7.14 (3.40–15.02) | <0.001* | 5.08 (2.40–10.78) | <0.001* | 5.28 (2.69–10.35) | <0.001* | 4.17 (2.11–8.25) | <0.001* |
Note: *Statistically significant.
Abbreviations: HR (95% CI), Hazard Ratio (95% confidence interval); NLR, Neutrophil-to-Lymphocyte Ratio; UISS, University of California, Los Angeles, integrated staging system; SSIGN, the stage, size, grade, and necrosis (SSIGN) score.